Midas Pharma GmbH

AI Quick Summary

MIDAS PHARMA Accelerate your development of Biologics and Drug Device Combinations and benefit from our expertise and tailored pharmaceutical support to safeguard your project executions – from drug discovery to commercial phase. Speed up your drug discovery and development with our comprehensive bioanalytical services for mAbs, ADCs, peptides, and nucleic acids. We offer a wide range of cutting-edge analytical methods, e.g., for structural and functional characterization of proteins, lead & clone selection, and biosimilar studies. Benefit from our pharma infrastructure e.g. for importing your product into the European Union, by using e.g. EU QP release services (in-house QPs), regulatory support, incl. marketing authorization holder ship and pharmacovigilance services (in-house EU-QPPV), or by exploiting our wholesale and supply chain expertise to import, launch and distribute your biopharmaceutical products. Discover Gx Inbeneo®, our next generation autoinjector, which addresses the challenges of subcutaneous self-administration of biopharmaceuticals with injection volumes of up to 3 ml and ultra-high viscosities. The Gx Inbeneo® platform offers quick customization to different formulations for faster time-to-market.

Organization Metadata

• Organization Name: Midas Pharma GmbH
• Date: 9/19/2024 2:16:47 PM
• Administrators:
  • Park Basel Area

Organization Description

MIDAS PHARMA

Accelerate your development of Biologics and Drug Device Combinations and benefit from our expertise and tailored pharmaceutical support to safeguard your project executions – from drug discovery to commercial phase.

Speed up your drug discovery and development with our comprehensive bioanalytical services for mAbs, ADCs, peptides, and nucleic acids. We offer a wide range of cutting-edge analytical methods, e.g., for structural and functional characterization of proteins, lead & clone selection, and biosimilar studies.

Benefit from our pharma infrastructure

• e.g. for importing your product into the European Union, by using e.g. EU QP release services (in-house QPs), regulatory support, incl. marketing authorization holder ship and pharmacovigilance services (in-house EU-QPPV), or
• by exploiting our wholesale and supply chain expertise to import, launch and distribute your biopharmaceutical products.

Discover Gx Inbeneo®, our next generation autoinjector, which addresses the challenges of subcutaneous self-administration of biopharmaceuticals with injection volumes of up to 3 ml and ultra-high viscosities. The Gx Inbeneo® platform offers quick customization to different formulations for faster time-to-market.